✂️ Minor papillotomy, major question.
Is this standard treatment effective for recurrent acute #pancreatitis with pancreas divisum?
Evan Fogel, MD, shares SHARP trial findings in @JAMA_current. #ManuscriptMonday
📑https://t.co/XGdA5y24py
#SHARPTrial#GITwitter
Presented at #EASL:
In two phase 3 trials, 19% of patients with chronic hepatitis B infection had a functional cure with the antisense oligonucleotide bepirovirsen, 24 weeks after stopping all HBV treatment; functional cure was not seen with placebo. Full results of the B-Well 1 and B-Well 2 trials: https://t.co/jcwJDIT5XR
Editorial: A Major Step toward a Cure for Hepatitis B Infection https://t.co/WzYWLC6lFU]
@EASLnews
Our study in ACG Summit.
The Enigma of Cholestasis in Hereditary Spherocytosis : Official journal of the American College of Gastroenterology | ACG https://t.co/ZueiUKvwqh
✅ Biopsies in suspected microscopic colitis
👉🏻 In this article Virine et al convincingly show that a diagnosis of microscopic colitis is always reached when evaluating biopsies of the ascending AND descending colon.
https://t.co/8WA73O5uFX
showPdf?
pii=S1542-3565%2820%2930206-8
If AFP level was 1-3 the last few times it was measured, & then "jumps" to 9, this should be a *POSITIVE* screening test for HCC (even if 9 is not above threshold):
👉Serial AFPs improve HCC screening sensitivity compared to fixed threshold
https://t.co/WHnKGGQC6i
Thrilled to see this international consensus work on EUS PPG presented today #DDW2025
29 advanced endoscopists and 18 hepatologists participated, led by the brilliant Dr. Thomas J. Wang 👏
All 22 statements reached consensus by Round 2
✅ This is a 🔝 development
🧰 Large working channel scope allows for more suction and of course, better instrumentation (can aspirate while having accessories inside the working channel) 👍🏻
#TLM2024
ALD & MetALD debrief by @juanpabloarab
➡️ Steroid tapering trial in alcohol-hepatitis ⬇️ infections vs standard approach
➡️ Many ALD pts are MetALD
➡️ In ALD, men and private insurance favors LT
➡️ Larsucosterol trial for alcohol-hepatitis
@AASLDtweets@alehlatam
Choosing Advanced Therapies for UC Based on Concomitant Immune Conditions & Extra-Intestinal Manifestations
▪️Plaque psoriasis ➡️ IL-23 & TNFi
▪️Psoriatic arthritis ➡️ IL-23, TNFi, JAKi
▪️Spondyloarthropathy ➡️ TNFi & JAKi
▪️Atopic dermatitis ➡️ JAKi
▪️Uveitis ➡️ TNFi
#ACG2024
👉🏽 Did you know curcumin mixed with black pepper & green tea extract pills (used for weight loss) are some of the most toxic OTC supplements for the liver?
👉🏽 @nagachalasani@AmJGastro lecture on Drug Induced Liver Disease #ACG2024@JasmohanBajaj@MLongMD
Lots of clinical pearls & practical tips from the colon & anorectal cases panel, including approach to #IBS, defecation & pelvic floor dysfunction, transition from pediatric to adult care, and dietary, psychological and pharmacologic therapy.
#HarvardMotility2024
But always rule out
❗local and ❗systemic risk factors.
Note:
❗PVT is not equal to EHPVO.
❗PVT with the young without demonstrable risk factors might be EHPVO.
❗❗❗If older age (>30 years) with new onset PVT, find out risk factors for the same.
#gitwitter#livertwitter
⚠️ Tests to do in non tumoral, non cirrhotic PVT. ⚠️
1. Protein C, S, ATIII Deficiency
2. Factor V Leiden Mutation
3. Prothombin 20210A gene mutation
4. JAK2 mutation
5. PNH workup
6. Serum Homocysteine,
7. APLA profile
8. If fitting, ANA
1/3
#gitwitter#livertwitter
Below ones might b expensive, but worth to do:
- activated Protein C resistance,
- genotyping of Factor V to search for G1691A mutation,
- Factor VIII assay,
- occult MPD by endogenous erythroid colony assessment
- bone marrow (helps in 30% EHPVO/PVT)
2/3
#gitwitter